| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 2674, 2019 | 273 | 2019 |
| A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the hippo pathway through FAK X Feng, N Arang, DC Rigiracciolo, JS Lee, H Yeerna, Z Wang, S Lubrano, ... Cancer cell 35 (3), 457-472. e5, 2019 | 211 | 2019 |
| A network of conserved synthetic lethal interactions for exploration of precision cancer therapy R Srivas, JP Shen, CC Yang, SM Sun, J Li, AM Gross, J Jensen, K Licon, ... Molecular cell 63 (3), 514-525, 2016 | 160 | 2016 |
| Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy V Wu, H Yeerna, N Nohata, J Chiou, O Harismendy, F Raimondi, A Inoue, ... Journal of biological chemistry 294 (29), 11062-11086, 2019 | 152 | 2019 |
| Assembly and activation of the Hippo signalome by FAT1 tumor suppressor D Martin, MS Degese, L Vitale-Cross, R Iglesias-Bartolome, JLC Valera, ... Nature communications 9 (1), 2372, 2018 | 138 | 2018 |
| APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy A Boichard, TV Pham, H Yeerna, A Goodman, P Tamayo, S Lippman, ... Oncoimmunology 8 (3), 1550341, 2019 | 68 | 2019 |
| Cannabinoids promote progression of HPV-positive head and neck squamous cell carcinoma via p38 MAPK activation C Liu, SH Sadat, K Ebisumoto, A Sakai, BA Panuganti, S Ren, Y Goto, ... Clinical Cancer Research 26 (11), 2693-2703, 2020 | 57 | 2020 |
| STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells JW Kim, C Berrios, M Kim, AE Schade, G Adelmant, H Yeerna, E Damato, ... Elife 9, e53003, 2020 | 47 | 2020 |
| Standing on the shoulders of mice K Medetgul-Ernar, MM Davis Immunity 55 (8), 1343-1353, 2022 | 41 | 2022 |
| DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes B Reilly, TN Tanaka, D Diep, H Yeerna, P Tamayo, K Zhang, R Bejar Blood advances 3 (19), 2845-2858, 2019 | 41 | 2019 |
| Decomposing oncogenic transcriptional signatures to generate maps of divergent cellular states JW Kim, OO Abudayyeh, H Yeerna, CH Yeang, M Stewart, RW Jenkins, ... Cell systems 5 (2), 105-118. e9, 2017 | 41 | 2017 |
| The GenePattern notebook environment M Reich, T Tabor, T Liefeld, H Thorvaldsdóttir, B Hill, P Tamayo, ... Cell systems 5 (2), 149-151. e1, 2017 | 40 | 2017 |
| A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction MP Menden, D Wang, Y Guan, MJ Mason, B Szalai, KC Bulusu, T Yu, ... BioRxiv, 200451, 2017 | 38* | 2017 |
| Comprehensive genomic profiling reveals diverse but actionable molecular portfolios across hematologic malignancies: implications for next generation clinical trials N Galanina, R Bejar, M Choi, A Goodman, M Wieduwilt, C Mulroney, ... Cancers 11 (1), 11, 2018 | 37 | 2018 |
| Metformin inhibits progression of head and neck squamous cell carcinoma by acting directly on carcinoma-initiating cells X Wu, H Yeerna, Y Goto, T Ando, VH Wu, X Zhang, Z Wang, ... Cancer research 79 (17), 4360-4370, 2019 | 36 | 2019 |
| Role of ultra‐violet mutational signature versus tumor mutation burden in predicting response to immunotherapy TV Pham, A Boichard, A Goodman, P Riviere, H Yeerna, P Tamayo, ... Molecular Oncology, 2020 | 35 | 2020 |
| Effect of diabetes mellitus on adipocyte‐derived stem cells in rat M Jumabay, JH Moon, H Yeerna, KI Boström Journal of cellular physiology 230 (11), 2821-2828, 2015 | 26 | 2015 |
| Tissue-and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples A Panda, A Yadav, H Yeerna, A Singh, M Biehl, M Lux, A Schulz, T Klecha, ... Nucleic acids research 48 (13), 7079-7098, 2020 | 18 | 2020 |
| Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition JP Shen, R Srivas, A Gross, J Li, EJ Jaehnig, SM Sun, ... Oncotarget 6 (34), 35755, 2015 | 14 | 2015 |
| KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor S Banerjee, H Yoon, S Ting, CM Tang, M Yebra, AT Wenzel, H Yeerna, ... Molecular cancer therapeutics 20 (10), 2035-2048, 2021 | 10 | 2021 |
PABLO TAMAYOProfessor, Division of Genomics and Precision Medicine, UC San DiegoVerified email at ucsd.edu
